FA (focal adhesion) and EMT were detected as REV-ERBβ target genes, therefore NR1D2 (REV-ERBβ) might serve as a potential target for GBM treatment via suppressing the invasion and migration of GBM cells (Yu et al., 2018; Chan et al., 2023). Here, NR1D2 is linked to glioblastoma.